Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Rogers Corp., Axos Financial: 5 Top Stock Gainers
By Rob Lenihan
Oct 30, 2020 4:22 PM EDT
PRESS RELEASES
FDA Grants Priority Review To Genentech's Esbriet (pirfenidone) For Unclassifiable Interstitial Lung Disease
By Business Wire
Jan 21, 2021 1:00 AM EST
PRESS RELEASES
Genentech's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Designation In Combination With Tecentriq For PD-L1-High Non-Small Cell Lung Cancer
By Business Wire
Jan 5, 2021 1:00 AM EST
PRESS RELEASES
Genentech's Faricimab Meets Primary Endpoint And Shows Strong Durability Across Two Global Phase III Studies For Diabetic Macular Edema, A Leading Cause Of Blindness
By Business Wire
Dec 21, 2020 1:00 AM EST
PRESS RELEASES
Genentech Announces New Data Reinforcing The Long-Term Benefit Of Venclexta-Based Combination For People With Relapsed Or Refractory Chronic Lymphocytic Leukemia
By Business Wire
Dec 5, 2020 12:45 PM EST
PRESS RELEASES
Rogers Corporation Appoints Megan Faust And Keith Larson To Its Board Of Directors
By Business Wire
Dec 3, 2020 12:00 PM EST
PRESS RELEASES
Genentech Announces FDA Approval Of Gavreto (pralsetinib) For People With Advanced Or Metastatic RET-Mutant And RET Fusion-Positive Thyroid Cancers
By Business Wire
Dec 1, 2020 3:15 PM EST
PRESS RELEASES
Genentech Announces FDA Approval Of Xolair (omalizumab) For Adults With Nasal Polyps
By Business Wire
Dec 1, 2020 11:34 AM EST
PRESS RELEASES
Genentech Announces FDA Approval Of Xofluza For The Prevention Of Influenza Following Contact With An Infected Person
By Business Wire
Nov 23, 2020 2:46 PM EST
PRESS RELEASES
OneOncology Partners With Genentech To Bring Personalized Cancer Research To Patients At Community Oncology Sites
By PR Newswire
Nov 23, 2020 6:15 AM EST
PRESS RELEASES
Leading Diagnostics Companies Join Forces To Establish The Access To Comprehensive Genomic Profiling Coalition (ACGP)
By PR Newswire
Nov 17, 2020 8:00 AM EST
INVESTING
Rogers Corp., Axos Financial: 5 Top Stock Gainers
By Rob Lenihan
Oct 30, 2020 4:22 PM EDT
PRESS RELEASES
Rogers Schedules Q3 2020 Earnings Call For October 29, 2020
By Business Wire
Oct 20, 2020 3:39 PM EDT
PRESS RELEASES
Genentech Announces Full FDA Approval For Venclexta Combinations For Acute Myeloid Leukemia
By Business Wire
Oct 16, 2020 7:30 PM EDT
PRESS RELEASES
Genentech Presents New 2-Year Data For Evrysdi (risdiplam) In Infants With Type 1 Spinal Muscular Atrophy (SMA)
By Business Wire
Sep 28, 2020 1:00 AM EDT
PRESS RELEASES
Inflazome Announces Acquisition By Roche
By Business Wire
Sep 21, 2020 2:00 AM EDT
PRESS RELEASES
Genentech Presents New Data From Multiple Phase III Studies Of Tecentriq In Triple-Negative Breast Cancer At ESMO Virtual Congress 2020
By Business Wire
Sep 19, 2020 10:20 AM EDT
PRESS RELEASES
Genentech's Phase III EMPACTA Study Showed Actemra Reduced The Likelihood Of Needing Mechanical Ventilation In Hospitalized Patients With COVID-19 Associated Pneumonia
By Business Wire
Sep 18, 2020 1:00 AM EDT
PRESS RELEASES
New Data Further Reinforce Genentech's Ocrevus (ocrelizumab) As A Highly Effective Treatment For People With Multiple Sclerosis
By Business Wire
Sep 11, 2020 1:00 AM EDT
PRESS RELEASES
New Data Show Genentech's Enspryng Significantly Reduces Severity And Risk Of Relapse In Neuromyelitis Optica Spectrum Disorder
By Business Wire
Sep 10, 2020 1:00 AM EDT
PRESS RELEASES
Genentech Expands Its Multiple Sclerosis Portfolio With Investigational BTK Inhibitor Fenebrutinib And Initiates Novel Clinical Trials For Ocrevus (ocrelizumab)
By Business Wire
Sep 9, 2020 1:00 AM EDT
PRESS RELEASES
Genentech Announces FDA Approval Of Gavreto (pralsetinib) For The Treatment Of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
By Business Wire
Sep 4, 2020 7:00 PM EDT
PRESS RELEASES
Genentech And Regeneron Collaborate To Significantly Increase Global Supply Of REGN-COV2 Investigational Antibody Combination For COVID-19
By Business Wire
Aug 19, 2020 1:00 AM EDT
PRESS RELEASES
FDA Approves Genentech's Enspryng For Neuromyelitis Optica Spectrum Disorder
By Business Wire
Aug 14, 2020 10:30 PM EDT
PRESS RELEASES
Genentech Provides Update On Phase III Studies Of Etrolizumab In People With Moderately To Severely Active Ulcerative Colitis
By Business Wire
Aug 10, 2020 1:00 AM EDT
